Skip to main content

Table 1 Study participants’ sociodemographic, health, and treatment characteristics by gender

From: The reliability, validity and factorial structure of the Swahili version of the 7-item generalized anxiety disorder scale (GAD-7) among adults living with HIV from Kilifi, Kenya

Characteristic Total sample N = 450 Female n = 356 Male n = 94
Age group
 18–24 years 20 (4.4%) 11 (3.1%) 9 (9.6%)
 25–35 years 87 (19.3%) 79 (22.2%) 8 (8.5%)
 36–49 years 223 (49.6%) 175 (49.2%) 48 (51.1%)
 50–60 years 120 (26.7%) 91 (25.6%) 29 (30.9%)
Marital status
 Married/cohabiting 196 (43.6%) 142 (39.9%) 54 (57.5%)
 Separated/divorced/widowed 197 (43.8%) 173 (48.6%) 24 (25.5%)
 Never married 57 (12.7%) 41 (11.5%) 16 (17.0%)
Education
 Tertiary 22 (4.9%) 13 (3.7%) 9 (9.6%)
 Secondary 66 (14.7%) 42 (11.8%) 24 (25.5%)
 Primary 239 (53.1%) 180 (50.6%) 59 (62.8%)
 None 123 (27.3%) 121 (34.0%) 2 (2.1%)
Employment
 Formally employed 53 (11.8%) 34 (9.6%) 19 (20.2%)
 Self-employed 117 (26.0%) 95 (26.7%) 22 (23.4%)
 Unemployed 269 (59.8%) 219 (61.5%) 50 (53.2%)
 Other 11 (2.4%) 8 (2.3%) 3 (3.2%)
Current chronic medical illnessa
 Present 37 (8.2%) 30 (8.4%) 7 (7.5%)
 Not present 413 (91.8%) 326 (91.6%) 87 (92.6%)
Antiretroviral regimenb
 First line 425 (95.3%) 335 (95.2%) 90 (95.7%)
 Second line 21 (4.7%) 17 (4.8%) 4 (4.3%)
WHO disease staging
 Stage 1 417 (93.7%) 334 (94.9%) 83 (89.3%)
 Stage 2 22 (4.9%) 14 (4.0%) 8 (8.6%)
 Stage 3 3 (0.7%) 2 (0.6%) 1 (1.1%)
 Stage 4 3 (0.7%) 2 (0.6%) 1 (1.1%)
  1. All variables had complete data except for antiretroviral regimen (4 missing observations) and WHO disease staging (5 missing observations)
  2. aBased on client self-reporting as informed by their clinician
  3. bAll the 21 participants on second-line medication were initially started on first line